The debate in the UK continues in this BMJ commentary from Friday. Too little evidence of efficacy too many resources spent in specialty memory clinics, not enough care throughout the disease.
Role of cholinesterase inhibitors in dementia care needs rethinking
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment